Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-07-23

FDA Approved: LURASIDONE HYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber Pharmaceuticals' supplemental ANDA for Lurasidone hydrochloride, enabling a generic version to be marketed in the U.S. Lurasidone is indicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lurasidone hydrochloride (Lurasidone hydrochloride)

Snippet

SUPPL AP for LURASIDONE HYDROCHLORIDE (LURASIDONE HYDROCHLORIDE)